Tarsus Pharmaceuticals (TARS) Q2 2024 Earnings

8MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.37
-1.25
-1.13
-1.01

Details

Expected EPS
-1.180937
Actual EPS
-1.01
Surprise EPS
0.17
Surprise Percent
+14.47%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -1.01 per share for Q2 2024.

0 Comments

Share your thoughts